Skip to main content

Tata 1mg announces complimentary health screening for doctors

 

The initiative is aimed at recognizing the contribution of doctors to India’s healthcare industry


Tata 1mg, a digital health company, has announced complimentary health check-ups for more than 1,000 doctors across India. The company will also felicitate 500 doctors this month as part of a nationwide campaign to recognize and appreciate the contribution of doctors to India’s healthcare industry.

The participant doctors would be checked on more than 70 health parameters, including liver function test, kidney function test, thyroid profile, glucose, lipid profile, vitamin D, and vitamin B12.

“Doctors are vulnerable to the same acute and chronic conditions as the patients they treat. Yet, in the pursuit of their profession, they often neglect their own health and do not extend the same empathy and care to themselves as they do to their patients. This is a matter of great concern as doctors are national assets, as seen by their relentless service during the pandemic,” said Prashant Nag, Head – of Clinical Pathology, Tata 1mg Labs

It will cover doctors, spread across hospitals in Delhi, Mumbai, Bengaluru, Kolkata, Pune, Hyderabad, Chennai, and Dehradun, with a complimentary Comprehensive Silver Full Body Checkup. Doctors can avail of this offer at their convenience through Tata 1mg’s expert home sample collection fleet in July and receive their reports from Tata 1mg Labs.

"Clinical Chemistry for a Healthier Life" is the focus of the 14th International Conference on Clinical and Medicinal Chemistry. on July 25–26, 2022, it will be a real joy to work alongside medical professionals from all over the world, allied health professionals, scientists, and academics.

For more details contact us on +44 7360516157

Or you can go through our webpage: https://clinicalchemistry.conferenceseries.com/registration.php 

Source:https://www.thehindubusinessline.com/companies/tata-1mg-announces-complimentary-health-screening-for-doctors/article65599344.ece


Location: United Kingdom

Comments

Post a Comment

Popular posts from this blog

New method leading to efficient production of next-generation Clinical Chemistry

Image
  The 14th International Conference on Clinical and Medicinal Chemistry scheduled on August 30-31, 2022 will feature presentations on the most recent scientific breakthroughs, technologies, and molecules. The conference will conclude with a "New Reagents, Instrumentation & Technologies" session hosted by the Clinical Chemistry 2022 committee in addition to the different scientific presentations. Late-breaking findings on significant clinical prospects from several treatment fields are presented in this session. The Keynote talk, planned by the Chair, will conclude the conference. New Reagents, Instrumentation & Technologies Reagents and equipment for clinical chemistry that make use of the most recent advancements and refinements for quantitative confirmation of substrates, synthetic chemicals, and electrolytes in human serum, plasma, or urine. It features both partially automated and fully automated analyzers to improve our general science reagents. The marke...
Read more

OMass Therapeutics Appoints Dr Jon Roffey as Vice President, Head of Medicinal Chemistry

Image
  Dr Roffey brings over 20 years of drug discovery experience gained in the pharmaceutical and biotechnology sectors, where he contributed to the development of multiple candidate drugs and late-stage clinical assets. He has extensive experience in a variety of therapeutic areas, including central nervous system, oncology and metabolic disorders across a range of therapeutic modalities. He joins from Nanna Therapeutics, where he was Head of Drug Discovery and led a portfolio of mitochondrial targeted programs to treat rare diseases.  Prior to that, he was Director of Chemistry at Azeria Therapeutics, a company he helped spin-out from the University of Cambridge.   Previously, at Cancer Research Technology, he was a Senior Group Leader and at Spirogen, he led and established the antibody drug conjugate programme, which led to the clinical development of vadastuximab talirine and rovalpituzumab tesirine.  He started his Medicinal chemistry career at Vernalis, as a...
Read more

Clinical Chemistry Analyzer Market Advanced Technologies and Growth Opportunities to Boost Industry Economy

Image
According to Report Ocean report Global Clinical Chemistry Analyzer Market: By Product Type (Analyzer, Reagent), By Test Type (Basic Metabolic Panel, Lipid Profile, Liver Profile, Electrolytes, Renal Profile, Thyroid Function, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) – By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, U.K, Germany, China, India, Japan, Brazil),  Global Clinical Chemistry Analyzer Market is projected to display a positive growth represented by a CAGR of 10.78% during 2018 2023. A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Clinical Chemistry Analyzer Market. The Global Clinical Chemistry Analyzer Market has been analyzed By Test Type (Basic Metabolic Panel, Lipid Profile, Liver Profile, Electrolytes, Renal Profile, Thyroid Function & Others)...
Read more